Researchers at the University of Toronto have invented a new method that uses DNA sequencing to measure metabolites. This ...

LONDON - Aptamer Group plc (AIM: APTA), the life sciences company specializing in the development of Optimer® binders, has issued new ordinary shares to compensate its Non-Executive Director, Tim ...

Insiders who bought Aptamer Group PLC ( LON:APTA ) stock lover the last 12 months are probably not as affected by ...

Researchers at the University of Toronto have developed a novel approach to measure metabolites using DNA sequencing.

LONDON - Aptamer Group plc (AIM: APTA), a developer of Optimer® binders for the life sciences industry, announced on Monday that Tim Sykes, a Non-Executive Director, has purchased 2,667,868 ...

Announcing a new publication for Acta Materia Medica journal. The binding affinity of aptamers to targets has a crucial role in the pharmaceutical and biosensing effects. Despite diverse ...

York-based biotech firm, the Aptamer Group, has reported “Revenue growth and significant commercial and technical progress” in its ...

Astellas Pharma seeks Japanese conditional approval of avacincaptad pegol intravitreal solution to treat geographic atrophy: Tokyo Thursday, February 6, 2025, 09:00 Hrs [IST] Aste ...

Despite diverse post-systematic evolution of ligands by exponential enrichment (post-SELEX) modifications explored in aptamer optimization, accurate prediction of high-affinity modification strategies ...

(Sharecast News) - Two director share purchases disclosed to the market in London on Monday involved insiders at the Conygar Investment Company and Aptamer Group. The Conygar Investment Company ...